These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26559597)

  • 1. How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions.
    Carney PA; Frederick PD; Reisch LM; Knezevich S; Piepkorn MW; Barnhill RL; Elder DE; Geller BM; Titus L; Weinstock MA; Nelson HD; Elmore JG
    J Am Acad Dermatol; 2016 Feb; 74(2):317-24; quiz 324.e1-8. PubMed ID: 26559597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Prior Diagnoses on Dermatopathologists' Interpretations of Melanocytic Lesions: A Randomized Controlled Trial.
    Elmore JG; Eguchi MM; Barnhill RL; Reisch LM; Elder DE; Piepkorn MW; Brunyé TT; Radick AC; Shucard HL; Knezevich SR; Kerr KF
    JAMA Dermatol; 2022 Sep; 158(9):1040-1047. PubMed ID: 35947391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatopathologists' Experience With and Perceptions of Patient Online Access to Pathologic Test Result Reports.
    Shucard H; Piepkorn MW; Reisch LM; Kerr KF; Radick AC; Wang PC; Knezevich SR; Barnhill RL; Elder DE; Elmore JG
    JAMA Dermatol; 2020 Mar; 156(3):320-324. PubMed ID: 31995131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions.
    Kerr KF; Elder DE; Piepkorn MW; Knezevich SR; Eguchi MM; Shucard HL; Reisch LM; Elmore JG; Barnhill RL
    JAMA Dermatol; 2023 Dec; 159(12):1315-1322. PubMed ID: 37938821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminology for melanocytic skin lesions and the MPATH-Dx classification schema: A survey of dermatopathologists.
    Radick AC; Reisch LM; Shucard HL; Piepkorn MW; Kerr KF; Elder DE; Barnhill RL; Knezevich SR; Oster N; Elmore JG
    J Cutan Pathol; 2021 Jun; 48(6):733-738. PubMed ID: 32935869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular testing practices and perceptions among dermatopathologists.
    Torre K; Jhorar P; Wu R; Pfeifer J; Elaba Z; Murphy M
    J Cutan Pathol; 2018 Jun; 45(6):387-394. PubMed ID: 29436726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatopathologist Perceptions of Overdiagnosis of Melanocytic Skin Lesions and Association With Diagnostic Behaviors.
    Kerr KF; Eguchi MM; Piepkorn MW; Radick AC; Reisch LM; Shucard HL; Knezevich SR; Barnhill RL; Elder DE; Elmore JG
    JAMA Dermatol; 2022 Jun; 158(6):675-679. PubMed ID: 35442415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.
    Piepkorn MW; Longton GM; Reisch LM; Elder DE; Pepe MS; Kerr KF; Tosteson ANA; Nelson HD; Knezevich S; Radick A; Shucard H; Onega T; Carney PA; Elmore JG; Barnhill RL
    JAMA Netw Open; 2019 Oct; 2(10):e1912597. PubMed ID: 31603483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malpractice and Patient Safety Concerns.
    Reisch LM; Flores MJ; Radick AC; Shucard HL; Kerr KF; Piepkorn MW; Barnhill RL; Elder DE; Knezevich SR; Elmore JG
    Am J Clin Pathol; 2020 Oct; 154(5):700-707. PubMed ID: 32651589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions.
    Titus LJ; Reisch LM; Tosteson ANA; Nelson HD; Frederick PD; Carney PA; Barnhill RL; Elder DE; Weinstock MA; Piepkorn MW; Elmore JG
    Am J Clin Pathol; 2018 Aug; 150(4):338-345. PubMed ID: 30007278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing comfort level with pediatric skin specimens among dermatopathologists and pediatric pathologists: A national cross-sectional survey.
    Enos T; Hughes C; Kelley S; Mir A; Rakheja D; Vandergriff T
    J Cutan Pathol; 2021 Sep; 48(9):1109-1114. PubMed ID: 33635594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.
    Emanuel PO; Andea AA; Vidal CI; Missall TA; Novoa RA; Bohlke AK; Hughes SR; Hurley MY; Kim J
    J Cutan Pathol; 2018 Nov; 45(11):839-846. PubMed ID: 30039879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who sends what: a comparison of dermatopathology referrals from dermatologists, pathologists and dermatopathologists.
    Goldenberg G; Camacho F; Gildea J; Golitz LE
    J Cutan Pathol; 2008 Jul; 35(7):658-61. PubMed ID: 18201232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.
    Geller BM; Frederick PD; Knezevich SR; Lott JP; Nelson HD; Titus LJ; Carney PA; Tosteson ANA; Onega TL; Barnhill RL; Weinstock MA; Elder DE; Piepkorn MW; Elmore JG
    Dermatol Surg; 2018 Feb; 44(2):177-185. PubMed ID: 28858936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi method.
    Carney PA; Reisch LM; Piepkorn MW; Barnhill RL; Elder DE; Knezevich S; Geller BM; Longton G; Elmore JG
    J Cutan Pathol; 2016 Oct; 43(10):830-7. PubMed ID: 27247109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malpractice in dermatopathology: principles, risk mitigation, and opportunities for improved care for the histologic diagnosis of melanoma and pigmented lesions.
    High WA
    Clin Lab Med; 2008 Jun; 28(2):261-84, vii. PubMed ID: 18436070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: how golden is the 'gold standard'?
    Braun RP; Gutkowicz-Krusin D; Rabinovitz H; Cognetta A; Hofmann-Wellenhof R; Ahlgrimm-Siess V; Polsky D; Oliviero M; Kolm I; Googe P; King R; Prieto VG; French L; Marghoob A; Mihm M
    Dermatology; 2012; 224(1):51-8. PubMed ID: 22433231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.
    Lott JP; Elmore JG; Zhao GA; Knezevich SR; Frederick PD; Reisch LM; Chu EY; Cook MG; Duncan LM; Elenitsas R; Gerami P; Landman G; Lowe L; Messina JL; Mihm MC; van den Oord JJ; Rabkin MS; Schmidt B; Shea CR; Yun SJ; Xu GX; Piepkorn MW; Elder DE; Barnhill RL;
    J Am Acad Dermatol; 2016 Aug; 75(2):356-63. PubMed ID: 27189823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography.
    Elmore JG; Taplin SH; Barlow WE; Cutter GR; D'Orsi CJ; Hendrick RE; Abraham LA; Fosse JS; Carney PA
    Radiology; 2005 Jul; 236(1):37-46. PubMed ID: 15987961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatopathologists' concerns and challenges with clinical information in the skin biopsy requisition form: a mixed-methods study.
    Comfere NI; Peters MS; Jenkins S; Lackore K; Yost K; Tilburt J
    J Cutan Pathol; 2015 May; 42(5):333-45. PubMed ID: 25757028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.